Viral Diseases
Research Areas
Products Related to Viral Diseases(300)
- GC78930NS2B/NS3-IN-3 dihydrochloridePurity: >99.00%
NS2B/NS3-IN-3 dihydrochloride is an inhibitor of Flavivirus NS2B-NS3 protease, with an IC 50 of 0.32 μM against Zika virus NS2B-NS3 protease.
- GC78942UH15-38 TFAPurity: >99.50%
UH15-38 TFA is a potent RIPK3 inhibitor with an IC 50 value of 20 nM.
- GC79142HA2 peptideCAS: 117138-19-9Purity: >98.00%
HA2 peptide is a potent pH-responsive fusion peptide derived from hemagglutinin ( HA ), corresponding to the N-terminal fusion peptide domain consisting of 23 amino acid residues of HIV-1 gp41 envelope glycoprotein.
- GC79426IFN-α Receptor Recognition Peptide 1 acetatePurity: >99.00%
IFN-α Receptor Recognition Peptide 1 acetate (IRRP1 acetate) is an amino acid synthetic peptide and also a regulator of IFN-α Receptor.
- GC79857Amenamevir-d 6Purity: >98%
Amenamevir -d 6 (ASP2151-d 6 ) is the deuterium labeled Amenamevir.
- GC79859Lenacapavir-d 5Purity: >98.00%
Lenacapavir -d 5 (GS-6207-d 5 ) is the deuterium labeled Lenacapavir.
- GC81395ddhCTP trisodium solution (100 mM ± 3 mM)Purity: >98.00%
ddhCTP trisodium solution (100 mM ± 3 mM) is an endogenously produced pyrimidine base analog with a K d of 17.0 nM for LLDH and an IC 50 of 55.8 μM for GAPDH.
- GC90631LL-37 (human) (scrambled) (trifluoroacetate salt)Purity: >95.00%
A negative control for LL-37 (human)
- GC90702Triciribine PhosphateCAS: 61966-08-3Purity: >95.00%
An Akt activation inhibitor and active metabolite of triciribine
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC78930 | NS2B/NS3-IN-3 dihydrochloride | - | >99.00% | |
NS2B/NS3-IN-3 dihydrochloride is an inhibitor of Flavivirus NS2B-NS3 protease, with an IC 50 of 0.32 μM against Zika virus NS2B-NS3 protease. | ||||
| GC78942 | UH15-38 TFA | - | >99.50% | |
UH15-38 TFA is a potent RIPK3 inhibitor with an IC 50 value of 20 nM. | ||||
| GC79142 | HA2 peptide | 117138-19-9 | >98.00% | |
HA2 peptide is a potent pH-responsive fusion peptide derived from hemagglutinin ( HA ), corresponding to the N-terminal fusion peptide domain consisting of 23 amino acid residues of HIV-1 gp41 envelope glycoprotein. | ||||
| GC79426 | IFN-α Receptor Recognition Peptide 1 acetate | - | >99.00% | |
IFN-α Receptor Recognition Peptide 1 acetate (IRRP1 acetate) is an amino acid synthetic peptide and also a regulator of IFN-α Receptor. | ||||
| GC79850 | rac-TNT-i | - | >98.00% | |
rac-TNT-i (rac-NPD3064) is the racomer of TNT-i. | ||||
| GC79857 | Amenamevir-d 6 | - | >98% | |
Amenamevir -d 6 (ASP2151-d 6 ) is the deuterium labeled Amenamevir. | ||||
| GC79859 | Lenacapavir-d 5 | - | >98.00% | |
Lenacapavir -d 5 (GS-6207-d 5 ) is the deuterium labeled Lenacapavir. | ||||
| GC80941 | RJS308 TFA | - | >98.00% | |
RJS308 TFA is a selective Cyclophilin A ( CypA) PROTAC degrader. | ||||
| GC81393 | KP-1212 | 114522-16-6 | >99.00% | |
KP-1212 is a nucleoside. | ||||
| GC81395 | ddhCTP trisodium solution (100 mM ± 3 mM) | - | >98.00% | |
ddhCTP trisodium solution (100 mM ± 3 mM) is an endogenously produced pyrimidine base analog with a K d of 17.0 nM for LLDH and an IC 50 of 55.8 μM for GAPDH. | ||||
| GC81654 | 2-5A TEA | 72351-33-8 | >98.00% | |
2-5A TEA (2′,5′-ApApA TEA) is a 5'-triphosphorylated (2',5') oligoadenylate. | ||||
| GC90483 | Magainin 1 (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial cationic peptide | ||||
| GC90488 | Tat-Beclin 1 (acetate) | - | >98.00% | |
An autophagy-inducing peptide | ||||
| GC90544 | Magainin 2 (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial cationic peptide | ||||
| GC90564 | LAP (trifluoroacetate salt) | - | >98.00% | |
An antiviral peptide | ||||
| GC90579 | Phenylglycine | 2835-06-5 | >95.00% | |
A building block | ||||
| GC90618 | SBP1 (trifluoroacetate salt) | - | >95.00% | |
A peptide | ||||
| GC90631 | LL-37 (human) (scrambled) (trifluoroacetate salt) | - | >95.00% | |
A negative control for LL-37 (human) | ||||
| GC90667 | Ravidasvir (hydrochloride) | 1303533-81-4 | >98.00% | |
An NS5A inhibitor | ||||
| GC90672 | L202 | 2170488-92-1 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90702 | Triciribine Phosphate | 61966-08-3 | >95.00% | |
An Akt activation inhibitor and active metabolite of triciribine | ||||
| GC90703 | IC8 | 2349307-32-8 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90772 | YK-009 | 2761458-86-8 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90785 | STING Agonist 23 | 2951078-67-2 | >99.50% | |
A STING agonist | ||||